LSO2 Antibody

What is LSO2 and what role does it play in cellular processes?

LSO2 is a ribosome-associated protein broadly conserved in eukaryotes, with CCDC124 (coiled-coil domain containing 124) identified as its human ortholog. LSO2 binds near the A site of the ribosome, specifically in a region that overlaps the GTPase activation center (GAC) . Through genome-wide crosslinking and immunoprecipitation experiments, researchers have demonstrated that LSO2:

• Crosslinks to 25S ribosomal RNA in the A site region

• Interacts with most tRNAs

• Stabilizes ribosomal subunit association

• Is required for translation recovery following stationary phase

The binding site of LSO2 is within 30 Å of a classical A site tRNA, positioning the protein to interact with ribosomal components critical for translation . When LSO2 is absent (in lso2Δ strains), cells experience severe translation defects during recovery from extended starvation, including:

• Global reduction in translation (more than 4-fold for most genes)

• Aberrant accumulation of ribosomes at start codons

• Depletion of ribosomes from stop codons

• Codon-specific changes in ribosome occupancy

How should researchers validate the specificity of LSO2 antibodies?

Establishing antibody specificity is crucial for reliable research involving LSO2. Comprehensive validation should include:

• Western blot validation:

  • Compare signal between wild-type and lso2Δ samples

  • Confirm expected molecular weight (approximately 14-15 kDa)

  • Test for cross-reactivity with human ortholog CCDC124

• Immunoprecipitation controls:

  • Perform IP followed by mass spectrometry to confirm LSO2 pull-down

  • Include size-matched input (SMI) controls processed identically except for IP omission

  • Use untagged strain controls if working with epitope-tagged systems

• Functional validation:

  • Confirm that antibody detection correlates with LSO2's known sedimentation profile on polysome gradients

  • Verify that antibody recognition is not affected by ribosome association state

  • Test recognition in multiple physiological conditions, particularly stationary phase and recovery

• Crosslinking specificity:

  • Analyze antibody performance in crosslinking studies with photoactivatable nucleosides

  • Compare signal enrichment against background in replicate experiments

  • Verify that crosslinked complexes yield expected RNA signatures

What are the typical applications of LSO2 antibodies in research?

LSO2 antibodies serve multiple research applications, particularly in studying ribosome-associated functions:

• Ribosome association studies:

  • Detecting LSO2 in polysome profile fractions

  • Monitoring changes in LSO2-ribosome association during stress conditions

  • Investigating relationships between LSO2 binding and translation efficiency

• RNA interaction analysis:

  • Enhanced photoactivatable ribonucleoside crosslinking and immunoprecipitation (ePAR-CLIP)

  • Identification of LSO2-bound RNA species (rRNA, tRNA, mRNA)

  • Mapping precise binding sites on ribosomal RNA

• Protein-protein interaction studies:

  • Co-immunoprecipitation of LSO2-associated proteins

  • Investigation of potential interactions with translation factors

  • Analysis of complex formation during different growth phases

• Localization studies:

  • Immunofluorescence microscopy to track LSO2 subcellular distribution

  • Co-localization with ribosomal markers

  • Monitoring relocalization during stress responses

How can LSO2 antibodies be used to investigate translation recovery mechanisms?

LSO2 plays a critical role in translation recovery after stationary phase, making antibodies against this protein valuable tools for investigating this process:

• Temporal analysis of LSO2-ribosome interactions:

  • Time-course immunoprecipitation during recovery from stationary phase

  • Correlation of LSO2 binding with restoration of translation activity

  • Analysis of changes in LSO2 post-translational modifications during recovery

• Ribosome state characterization:

  • Investigation of LSO2's role in preventing ribosome stalling at start codons

  • Analysis of how LSO2 facilitates ribosome progression through open reading frames

  • Examination of LSO2's impact on stop codon recognition and termination

• Comparative studies between species:

  • Assessment of human CCDC124 function compared to yeast LSO2

  • Investigation of conservation in ribosome binding activity

  • Evaluation of ortholog complementation in lso2Δ yeast strains

• Integration with ribosome profiling data:

  • Correlation of LSO2 binding sites with ribosome occupancy patterns

  • Analysis of footprint size distributions (15-34 nucleotides) in the presence/absence of LSO2

  • Investigation of LSO2's role in quality control intermediates versus elongating ribosomes

What experimental design is optimal for LSO2 antibody-based crosslinking studies?

Based on successful ePAR-CLIP studies with LSO2, optimal experimental design includes:

• Crosslinking optimization:

  • Growth of cells with 4-thiouracil for efficient UV-crosslinking at 365 nm

  • Verification that crosslinking conditions don't affect LSO2's ribosome co-sedimentation pattern

  • Controlled RNase I digestion to preserve LSO2-bound RNA fragments

• Stringent controls and replication:

  • Parallel processing of size-matched input (SMI) as a negative control

  • Inclusion of anti-Myc IP from untagged strains as additional control

  • Performance of independent biological replicates to ensure reproducibility

• Library preparation and analysis:

  • Deep sequencing of crosslinked RNA fragments

  • Collapsing of reads to remove PCR duplicates

  • Mapping to modified genome containing single copies of rDNA locus and unique tRNA genes

  • Application of peak identification algorithms with stringent enrichment criteria

• Data validation:

  • Correlation analysis between IP replicates (R² = 0.996 observed in published work)

  • Positive correlation between IP and SMI relative abundances (Pearson r > 0.7)

  • Structural analysis of identified binding sites in context of ribosome architecture

How do LSO2 antibodies facilitate the study of LSO2's role in ribosome stabilization?

LSO2 antibodies can significantly advance our understanding of LSO2's role in stabilizing ribosomes:

• In vitro ribosome association assays:

  • Quantification of monosome versus free subunit distribution in the presence of recombinant LSO2

  • Comparison with antibody-based depletion of LSO2 from extract

  • Analysis at varying magnesium concentrations (particularly near-physiological 3 mM)

• Structural studies:

  • Immunogold labeling for electron microscopy localization of LSO2 on ribosomes

  • Correlation with cryo-EM studies of ribosome-LSO2 complexes

  • Mapping of LSO2 position relative to the tRNA channel and GAC

• Functional recovery experiments:

  • Analysis of LSO2 recruitment to ribosomes during stress recovery

  • Correlation of binding with restoration of translation activity

  • Investigation of factors that modulate LSO2-ribosome interactions

• Mutational analysis:

  • Study of how mutations in LSO2's ribosome-binding domains affect function

  • Comparison of wild-type and mutant LSO2 binding using antibody detection

  • Assessment of human ortholog CCDC124 binding to ribosomes from different species

What protocols are recommended for immunoprecipitation using LSO2 antibodies?

For successful immunoprecipitation of LSO2 and associated complexes:

• Sample preparation:

  • Use gentle lysis conditions to preserve ribosome-LSO2 interactions

  • Include translation inhibitors (e.g., cycloheximide) if studying ribosome-bound LSO2

  • Maintain physiological magnesium concentration (3 mM) to preserve ribosome integrity

• Crosslinking (if applicable):

  • Grow cells with 4-thiouracil if performing UV crosslinking (365 nm)

  • Verify that crosslinking doesn't affect LSO2's ribosome association pattern

  • Apply limited RNase I digestion to preserve specifically bound RNA fragments

• Immunoprecipitation procedure:

  • Pre-clear lysates to reduce background

  • Incubate with optimized antibody concentration at 4°C

  • Include appropriate negative controls (untagged strain, non-specific antibody)

• Washing and elution:

  • Apply stringent washes to remove non-specific interactions

  • Elute bound complexes using conditions appropriate for downstream applications

  • For RNA analysis, treat with proteinase K to release crosslinked RNA

• Validation and analysis:

  • Verify IP efficiency by western blotting

  • For RNA studies, perform deep sequencing of bound fragments

  • Compare results across biological replicates to ensure reproducibility

How should researchers interpret tRNA crosslinking data with LSO2 antibodies?

The interpretation of tRNA crosslinking data requires careful analysis:

• Enrichment analysis:

  • Apply minimum read cutoffs (e.g., 64 reads across all libraries)

  • Identify tRNAs with ≥4-fold enrichment in IP versus controls

  • Analyze correlation between replicate IPs (R² = 0.996 in published work)

• Biological significance assessment:

  • Consider LSO2's binding position near the A site (within 30 Å of classical A site tRNA)

  • Analyze whether LSO2 can interact with both A and P site tRNAs

  • Evaluate relationship between tRNA binding and LSO2's role in translation recovery

• Structural context interpretation:

  • Relate tRNA crosslinking to LSO2's 25S rRNA binding site

  • Consider LSO2's potential impact on tRNA accommodation and translocation

  • Analyze whether LSO2 binding affects tRNA recognition or GTPase activation

• Comparative analysis:

  • Examine differences in tRNA enrichment patterns

  • Correlate with codon-specific changes in ribosome occupancy in lso2Δ

  • Compare with other ribosome-binding factors that interact with the tRNA channel

What controls are essential when using LSO2 antibodies for ribosome profiling studies?

When combining LSO2 antibodies with ribosome profiling:

• Strain controls:

  • Wild-type versus lso2Δ comparisons

  • Complementation with tagged LSO2 to verify function

  • Validation that tagging doesn't affect ribosome co-sedimentation patterns

• Technical controls:

  • Size-matched input samples processed in parallel with IP samples

  • Untagged strain controls for antibody specificity

  • No-crosslinking controls if using crosslinking approaches

• Data analysis controls:

  • Analysis of different footprint size ranges (15-34 nucleotides)

  • Distinction between quality control intermediates (15-18 mers) and elongating ribosomes (20-22 mers versus 28-34 mers)

  • Correlation between biological replicates

• Physiological condition controls:

  • Comparison of different growth phases (logarithmic, stationary, recovery)

  • Analysis under different stress conditions

  • Time-course studies during recovery from stationary phase

How should researchers interpret changes in ribosome distribution patterns related to LSO2?

The absence of LSO2 causes specific changes in ribosome distribution that require careful interpretation:

What biochemical validation approaches complement LSO2 antibody studies?

Antibody-based studies of LSO2 should be complemented with biochemical validation:

• In vitro ribosome binding assays:

  • Gradient association assays using purified components

  • Quantification of monosome formation with/without recombinant LSO2

  • Analysis at varying magnesium concentrations (particularly 3 mM)

• Mutational analysis:

  • Structure-guided mutagenesis of LSO2 binding domains

  • Assessment of mutant binding using antibody detection

  • Correlation of binding defects with functional consequences

• Crosslinking validation:

  • Comparison of in vivo crosslinking with in vitro reconstituted systems

  • Analysis of crosslinking patterns with purified components

  • Structural interpretation of binding sites

• Functional complementation:

  • Testing human ortholog CCDC124 in yeast lso2Δ strains

  • Assessment of conservation of ribosome binding activity

  • Correlation of binding with functional rescue

How do post-translational modifications affect LSO2 antibody recognition and function?

While current research lacks detailed information on LSO2 post-translational modifications, this represents an important area for investigation:

• Potential modification types:

  • As a stress-responsive protein, LSO2 may be regulated by phosphorylation

  • Ubiquitination might control LSO2 levels during recovery from stationary phase

  • Other modifications could modulate ribosome binding activity

• Antibody selection considerations:

  • Different antibodies may have varying sensitivities to modified epitopes

  • Use multiple antibodies targeting different regions of LSO2

  • Consider generating modification-specific antibodies if particular PTMs are identified

• Experimental approaches:

  • Compare LSO2 antibody recognition across growth conditions

  • Analyze LSO2 by mass spectrometry to identify modifications

  • Correlate modifications with functional changes during stress/recovery

• Functional significance:

  • Investigate whether modifications regulate LSO2's association with ribosomes

  • Analyze impact on translation recovery efficiency

  • Compare modification patterns between yeast LSO2 and human CCDC124